PROM1 and hepatocellular carcinoma: Moreover, based on the expression of AFP and CD133 (a typical stem cell marker), Dai et al. classified HCC into four groups (CD133+AFP+, CD133-AFP-, CD133+AFP- and CD133-AFP+ HCC) with significantly distinct clinicopathological features and prognosis78.